Press release
Angiotensin II Receptor Blockers Market Trends, Growth Forecast & Top Players 2025 | Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd.
Angiotensin II Receptor Blockers Market
The Angiotensin II Receptor Blockers Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/angiotensin-ii-receptor-blockers-market?sz
The Angiotensin II Receptor Blockers (ARBs) Market refers to the global industry focused on medications that block angiotensin II receptors, helping to lower blood pressure and treat heart failure and chronic kidney disease. These drugs are widely prescribed due to their effectiveness and fewer side effects compared to other antihypertensives, driving consistent demand across healthcare systems worldwide.
Major players in the Angiotensin II Receptor Blockers Market
The prominent players in Angiotensin II Receptor Blockers market research report are: Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd, Novartis AG, Takeda Pharmaceutical Co. Ltd, AstraZeneca, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim, Abbive Inc, Zydus Cadila among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
On March 26, 2024, Otsuka Pharmaceutical Co., Ltd. announced that Novartis Pharma K.K. received regulatory approval for Entresto Granular Tablets for Pediatric Use (12.5 mg / 31.25 mg). These tablets, containing sacubitril valsartan sodium hydrate, are part of the angiotensin receptor neprilysin inhibitor (ARNI) class and are now approved for pediatric patients.
On February 17, 2023, Travere Therapeutics, Inc. announced that the U.S. FDA had granted accelerated approval to FILSPARI (sparsentan). This approval allows use of the drug to help reduce proteinuria in adults with primary IgA nephropathy (IgAN) who are at risk of rapid disease progression, typically defined by a urine protein-to-creatinine ratio (UPCR) of ≥1.5 g/g.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/angiotensin-ii-receptor-blockers-market
Market Segments
By Type: Valsartan, Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Others.
By Application: Heart Failure, Hypertension, Kidney Disease, Others.
By End-Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other.
The Angiotensin II Receptor Blockers industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Angiotensin II Receptor Blockers Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin II Receptor Blockers Market Trends, Growth Forecast & Top Players 2025 | Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd. here
News-ID: 4050222 • Views: …
More Releases from DataM Intelligence 4Market Research
Oral Mucositis Market Poised for Strong Growth Driven by Rising Cancer Therapies …
Market Size and Growth:
The Oral Mucositis Market reached US$ 1.62 billion in 2023 and is expected to reach US$ 2.30 billion by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.
Oral Mucositis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
Global Medical Second Opinion Market Soars as Patients Seek Accurate Diagnoses & …
Market Size and Growth:
The Global Medical Second Opinion Market size reached USD 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to USD 12,701.8 million by 2031. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period 2024-2031.
Medical Second Opinion Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and…
Global Cancer Molecular Diagnostics Market Set for Strong Growth with Breakthrou …
Market Overview:
The Global Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031.
Cancer Molecular Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…
Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalenc …
Market Size and Growth:
The Gout Therapeutics Market size was valued USD 1.9 billion in 2021 and is estimated to reach USD 4.1 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).
Gout Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Angiotensin
Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blo …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Angiotensin Receptor Blockers (ARBs) Market Through 2025?
The market size of angiotensin receptor blockers (ARBs) has seen a consistent growth in the past years. The market is projected to expand from $8.51 billion in 2024 to $8.87 billion in 2025, with a compound annual growth rate (CAGR)…
Angiotensin Converting Enzyme (ACE) Inhibitors Market
Angiotensin Converting Enzyme (ACE) inhibitors are a class of pharmaceutical drugs used primarily for the treatment of high blood pressure (hypertension), heart failure, and chronic kidney diseases. These medications help to relax blood vessels, thereby lowering blood pressure and improving heart function. ACE inhibitors block the activity of the enzyme that converts angiotensin I to angiotensin II, a peptide that narrows blood vessels. By inhibiting this conversion, ACE inhibitors enable…
Angiotensin Converting Enzyme (ACE) Inhibitors Market: An Overview
Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications widely used in the treatment of various cardiovascular conditions, primarily high blood pressure (hypertension) and heart failure. These drugs work by blocking the action of the enzyme angiotensin-converting enzyme, which is responsible for producing a substance called angiotensin II. Angiotensin II constricts blood vessels and raises blood pressure. By inhibiting this enzyme, ACE inhibitors help relax blood vessels, lower blood…
Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative …
What market dynamics are playing a key role in accelerating the growth of the angiotensin receptor blockers (arbs) market?
The upward trend of cardiovascular diseases is predicted to fuel advancements in the angiotensin receptor blockers market. Often related to the accumulation of fatty components within the arteries (atherosclerosis) and heightened probability of blood clots, cardiovascular disease (CVD) influences the heart or blood vessels. The function of angiotensin receptor blockers is to…
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
